STAT

Is there a future for a Zika vaccine?

The news that the company making the front-running candidate for a Zika vaccine pulled the plug on it shows that bringing one to market will be difficult.
Aedes aegypti mosquitoes, responsible for transmitting Zika, sit in a Petri dish at the Fiocruz Institute in Recife, Brazil.

When a leading vaccine manufacturer announced earlier this month that it was pulling out of the race to develop a vaccine against the Zika virus, it effectively shelved what was widely considered to be one of front-running candidates. Along with the dramatic drop in the number of new cases of Zika in recent months, does this signal that the threat has now passed, or does it mean we are now no closer to a vaccine should a resurgence of the disease eventually occur?

Neither, in fact. When Zika does start to spread again, which seems likely, the loss of this one vaccine is unfortunate, particularly because it is from a major currently in the works.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks